-
Je něco špatně v tomto záznamu ?
Associations between adverse pregnancy outcomes and cognitive impairment and dementia: a systematic review and meta-analysis
EC. Miller, P. Conley, M. Alirezaei, K. Wolfova, MM. Gonzales, ZS. Tan, SE. Tom, LM. Yee, AM. Brickman, NA. Bello
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, systematický přehled, metaanalýza
Grantová podpora
K23 HL136853
NHLBI NIH HHS - United States
K23 NS107645
NINDS NIH HHS - United States
R01 AG085475
NIA NIH HHS - United States
R01 NS122815
NINDS NIH HHS - United States
NLK
Directory of Open Access Journals
od 2020 do 2024
ROAD: Directory of Open Access Scholarly Resources
od 2020
- MeSH
- demence * epidemiologie psychologie MeSH
- kognitivní dysfunkce * epidemiologie psychologie MeSH
- lidé MeSH
- těhotenství MeSH
- výsledek těhotenství * epidemiologie psychologie MeSH
- Check Tag
- lidé MeSH
- těhotenství MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- metaanalýza MeSH
- systematický přehled MeSH
BACKGROUND: Individuals with adverse pregnancy outcomes have an increased risk of cerebrovascular disease, but the association between adverse pregnancy outcomes and cognitive impairment and dementia is less well established. We aimed to synthesise, combine, and assess the growing body of data examining the associations between adverse pregnancy outcomes and mild cognitive impairment and dementia in parous women. METHODS: In this systematic review and meta-analysis, we searched PubMed (MEDLINE), Web of Science, and Embase from database inception up to July 18, 2024, with no language restrictions, for observational studies or clinical trials that reported mild cognitive impairment or dementia as outcomes and included female individuals or women who had an adverse pregnancy outcome, including hypertensive disorders of pregnancy, gestational diabetes, stillbirth, fetal growth restriction, preterm birth, or placental abruption. We excluded studies of men, nulliparous women, women with pre-pregnancy conditions associated with impaired cognition, and studies examining cognitive impairment within 6 months of pregnancy. Database searches were supplemented by manual review of the reference lists of included studies. If studies met eligibility criteria but did not have sufficient data for meta-analysis (ie, did not report a summary statistic or a hazard ratio [HR] for outcome estimation), they were included in the systematic review and excluded from the meta-analysis. After removing duplicates, two investigators independently screened titles and abstracts using Covidence software, with potentially eligible studies undergoing full-text review by the same reviewers, with further review by a third reviewer and disagreements resolved by discussion and group consensus. Study quality was assessed and summary statistics extracted by two reviewers independently. The primary outcomes of our study were mild cognitive impairment, all-cause dementia, Alzheimer's disease, and vascular dementia. Heterogeneity was measured using the Q test and I2 statistic, and we used random-effects models with inverse-variance weighting to assess the association between adverse pregnancy outcome and primary outcomes with sufficient meta-analysable data via pooled adjusted HRs and 95% CIs. The study protocol was registered with PROSPERO, CRD42023453511. FINDINGS: Of 11 251 publications identified, 15 studies (including 7 347 202 participants) met inclusion criteria for the systematic review, and 11 studies (6 263 431 participants) had sufficient data for meta-analysis. A history of any adverse pregnancy outcome was associated with higher risk of all-cause dementia (adjusted HR 1·32 [95% CI 1·17-1·49]; I2= 80%), Alzheimer's disease (1·26 [1·04-1·53]; I2=63%), and vascular dementia (1·94 [1·70-2·21]; I2=0%). A history of any hypertensive disorder of pregnancy was significantly associated with all-cause dementia (1·32 [1·11-1·57]; I2=74%) and vascular dementia (1·78 [1·46-2·17]; I2=0%), but not Alzheimer's disease (1·24 [0·98-1·57]; I2=66%). Stillbirth was not significantly associated with higher risk of all-cause dementia (1·26 [95% CI 0·93-1·71]; I2=62%). In individual studies, similar effect directions were observed for preterm birth and fetal growth restriction, but data were insufficient for meta-analysis. INTERPRETATION: Given their increased risk of dementia, women with a history of adverse pregnancy outcomes should be evaluated for additional dementia risk factors and monitored closely for any signs of cognitive decline. Furthermore, to obtain more reliable findings, future studies should measure both exposures and outcomes prospectively and objectively. FUNDING: National Institutes of Health, National Institute of Neurological Disorders and Stroke, National Institute on Aging, and National Heart, Lung and Blood Institute.
Department of Cardiology Smidt Heart Institute Cedars Sinai Medical Center Los Angeles CA USA
Department of Epidemiology 2nd Faculty of Medicine Charles University Prague Czech Republic
Department of Neurology Columbia University New York NY USA
Department of Neurology Tehran University of Medical Sciences Tehran Iran
Department of Obstetrics and Gynecology Northwestern University Chicago IL USA
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25003126
- 003
- CZ-PrNML
- 005
- 20250206104044.0
- 007
- ta
- 008
- 250121s2024 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.lanhl.2024.100660 $2 doi
- 035 __
- $a (PubMed)39675366
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Miller, Eliza C $u Department of Neurology, Columbia University, New York, NY, USA. Electronic address: ecm2137@cumc.columbia.edu
- 245 10
- $a Associations between adverse pregnancy outcomes and cognitive impairment and dementia: a systematic review and meta-analysis / $c EC. Miller, P. Conley, M. Alirezaei, K. Wolfova, MM. Gonzales, ZS. Tan, SE. Tom, LM. Yee, AM. Brickman, NA. Bello
- 520 9_
- $a BACKGROUND: Individuals with adverse pregnancy outcomes have an increased risk of cerebrovascular disease, but the association between adverse pregnancy outcomes and cognitive impairment and dementia is less well established. We aimed to synthesise, combine, and assess the growing body of data examining the associations between adverse pregnancy outcomes and mild cognitive impairment and dementia in parous women. METHODS: In this systematic review and meta-analysis, we searched PubMed (MEDLINE), Web of Science, and Embase from database inception up to July 18, 2024, with no language restrictions, for observational studies or clinical trials that reported mild cognitive impairment or dementia as outcomes and included female individuals or women who had an adverse pregnancy outcome, including hypertensive disorders of pregnancy, gestational diabetes, stillbirth, fetal growth restriction, preterm birth, or placental abruption. We excluded studies of men, nulliparous women, women with pre-pregnancy conditions associated with impaired cognition, and studies examining cognitive impairment within 6 months of pregnancy. Database searches were supplemented by manual review of the reference lists of included studies. If studies met eligibility criteria but did not have sufficient data for meta-analysis (ie, did not report a summary statistic or a hazard ratio [HR] for outcome estimation), they were included in the systematic review and excluded from the meta-analysis. After removing duplicates, two investigators independently screened titles and abstracts using Covidence software, with potentially eligible studies undergoing full-text review by the same reviewers, with further review by a third reviewer and disagreements resolved by discussion and group consensus. Study quality was assessed and summary statistics extracted by two reviewers independently. The primary outcomes of our study were mild cognitive impairment, all-cause dementia, Alzheimer's disease, and vascular dementia. Heterogeneity was measured using the Q test and I2 statistic, and we used random-effects models with inverse-variance weighting to assess the association between adverse pregnancy outcome and primary outcomes with sufficient meta-analysable data via pooled adjusted HRs and 95% CIs. The study protocol was registered with PROSPERO, CRD42023453511. FINDINGS: Of 11 251 publications identified, 15 studies (including 7 347 202 participants) met inclusion criteria for the systematic review, and 11 studies (6 263 431 participants) had sufficient data for meta-analysis. A history of any adverse pregnancy outcome was associated with higher risk of all-cause dementia (adjusted HR 1·32 [95% CI 1·17-1·49]; I2= 80%), Alzheimer's disease (1·26 [1·04-1·53]; I2=63%), and vascular dementia (1·94 [1·70-2·21]; I2=0%). A history of any hypertensive disorder of pregnancy was significantly associated with all-cause dementia (1·32 [1·11-1·57]; I2=74%) and vascular dementia (1·78 [1·46-2·17]; I2=0%), but not Alzheimer's disease (1·24 [0·98-1·57]; I2=66%). Stillbirth was not significantly associated with higher risk of all-cause dementia (1·26 [95% CI 0·93-1·71]; I2=62%). In individual studies, similar effect directions were observed for preterm birth and fetal growth restriction, but data were insufficient for meta-analysis. INTERPRETATION: Given their increased risk of dementia, women with a history of adverse pregnancy outcomes should be evaluated for additional dementia risk factors and monitored closely for any signs of cognitive decline. Furthermore, to obtain more reliable findings, future studies should measure both exposures and outcomes prospectively and objectively. FUNDING: National Institutes of Health, National Institute of Neurological Disorders and Stroke, National Institute on Aging, and National Heart, Lung and Blood Institute.
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a těhotenství $7 D011247
- 650 12
- $a kognitivní dysfunkce $x epidemiologie $x psychologie $7 D060825
- 650 12
- $a demence $x epidemiologie $x psychologie $7 D003704
- 650 12
- $a výsledek těhotenství $x epidemiologie $x psychologie $7 D011256
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a systematický přehled $7 D000078182
- 655 _2
- $a metaanalýza $7 D017418
- 700 1_
- $a Conley, Patrick $u Department of Cardiology, Smidt Heart Institute, Cedars Sinai Medical Center, Los Angeles, CA, USA
- 700 1_
- $a Alirezaei, Mohammad $u Department of Neurology, Tehran University of Medical Sciences, Tehran, Iran
- 700 1_
- $a Wolfova, Katrin $u Department of Neurology, Columbia University, New York, NY, USA; Department of Epidemiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Gonzales, Mitzi M $u Department of Neurology, Jona Goldrich Center for Alzheimer's and Memory Disorders, Cedars Sinai Medical Center, Los Angeles, CA, USA
- 700 1_
- $a Tan, Zaldy S $u Department of Neurology, Jona Goldrich Center for Alzheimer's and Memory Disorders, Cedars Sinai Medical Center, Los Angeles, CA, USA
- 700 1_
- $a Tom, Sarah E $u Department of Neurology, Columbia University, New York, NY, USA
- 700 1_
- $a Yee, Lynn M $u Department of Obstetrics and Gynecology, Northwestern University, Chicago, IL, USA
- 700 1_
- $a Brickman, Adam M $u Department of Neurology, Columbia University, New York, NY, USA
- 700 1_
- $a Bello, Natalie A $u Department of Cardiology, Smidt Heart Institute, Cedars Sinai Medical Center, Los Angeles, CA, USA
- 773 0_
- $w MED00209785 $t The lancet. Healthy longevity $x 2666-7568 $g Roč. 5, č. 12 (2024), s. 100660
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39675366 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250121 $b ABA008
- 991 __
- $a 20250206104040 $b ABA008
- 999 __
- $a ok $b bmc $g 2263089 $s 1239133
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 5 $c 12 $d 100660 $e 20241212 $i 2666-7568 $m The lancet. Healthy longevity $n Lancet Healthy Longev $x MED00209785
- GRA __
- $a K23 HL136853 $p NHLBI NIH HHS $2 United States
- GRA __
- $a K23 NS107645 $p NINDS NIH HHS $2 United States
- GRA __
- $a R01 AG085475 $p NIA NIH HHS $2 United States
- GRA __
- $a R01 NS122815 $p NINDS NIH HHS $2 United States
- LZP __
- $a Pubmed-20250121